Paul A. Grayson - 18 Aug 2023 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role: Director
Signature: /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol: SKYE
Transactions as of: 18 Aug 2023
Net transactions value: $0
Form type: 3
Filing time: 22 Aug 2023, 17:19:15 UTC
Next filing: 29 Aug 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.